Stephanie Gentile

About Stephanie

Stephanie Gentile's practice focuses on taxation of partnerships and corporations in a wide variety of business matters, including mergers and acquisitions for strategic acquirors and private equity sponsors, fund formations and restructurings.

View full bio

Experience

Alani Nu’s $1.8 Billion Sale to Celsius

February 20, 2025

Cooley advised Katy Hearn and Haydn Schneider, co-founders of Alani Nu, in connection with Celsius Holdings’ (Nasdaq: CELH) definitive agreement to acquire the company for $1.8 billion in cash and stock.

Related contacts

Bill Roegge

Partner, New York

Stephanie Leigh

Paralegal Specialist, San Diego

Stephanie Gentile

Partner, New York

Jeremy Morrison

Partner, Washington, DC

Vicky Kandabarow

Associate, Washington, DC

Kyle Hess

Associate, New York

Wesley Dietrich

Associate, Washington, DC

Sharon Connaughton

Special Counsel, Washington, DC

Todd Gluth

Partner, San Diego

Sarah Lightdale

Partner, New York

Eileen Marshall

Partner, Washington, DC

Mark Windfeld-Hansen

Senior Counsel, Palo Alto

Julia R. Brinton

Special Counsel, Washington, DC

William Corcoran

Of Counsel, Boston

Related Practices & Industries

Mergers and Acquisitions

Antitrust and Competition

CooleyREG

Tax

Food and Beverage

Securities Litigation + Enforcement

Alumis Announces Merger With ACELYRIN

February 6, 2025

Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.

Related contacts

Jamie Leigh

Partner, San Francisco

David Peinsipp

Partner, San Francisco

Ben Beerle

Partner, San Francisco

Kristin VanderPas

Partner, San Francisco

Polina A. Demina

Special Counsel, New York

Sangitha Palaniappa

Associate, Palo Alto

Christine Turner

Associate, Colorado

Shaun (Tianjie) Wang

Associate, New York

Megan Browdie

Partner, Washington, DC

Lauren Creel

Partner, Palo Alto

Ross Eberly

Partner, Santa Monica

Stephanie Gentile

Partner, New York

Dr. Kate Hillier

Partner, Palo Alto

Sarah Lightdale

Partner, New York

Phil Mitchell

Partner, New York

Jeremy Morrison

Partner, Washington, DC

Alessandra Murata

Partner, Palo Alto

Jennifer Raab

Partner, Palo Alto

Patrick Van Eecke

Partner, Brussels

Natasha Leskovsek

Of Counsel, Washington, DC

Julia R. Brinton

Special Counsel, Washington, DC

Andrew Epstein

Special Counsel, Seattle

Caroline Vu

Special Counsel, Palo Alto

Christopher Andrews

Associate, New York

Dannielle Antone

Associate, San Francisco

Elizabeth Caruso

Associate, New York

Tamara Chin Loy

Associate, Washington, DC

Navya Dasari

Associate, New York

Joshua Elefant

Associate, Palo Alto

Winda Fung

Associate, Santa Monica

Gary Warren Hunt III

Associate, Washington, DC

Rachel F. Katz

Special Counsel, New York

Wyatt Kernell

Associate, Colorado

Kristina Krasnikova

Associate, Palo Alto

Sunny J. Levine

Associate, Colorado

Amanda Lindner

Associate, New York

Jayne M. Munger

Associate, New York

Julianne Orr

Associate, San Francisco

Michael Pelle

Associate, New York

Breanna Qin

Associate, Palo Alto

Bartholomäus Regenhardt

Associate, Brussels

Jesse Schulman

Associate, Colorado

Freddy Yip

Associate, Hong Kong

Isabella Ysebrands

Associate, San Francisco

Related Practices & Industries

Mergers and Acquisitions

Life Sciences

Public Companies

Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement

January 31, 2025

Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.

Related contacts

Carlos Ramirez

Partner, San Diego

Mark Weeks

Partner, Palo Alto

Charlie Kim

Partner, San Diego

Christine S. Kim

Associate, San Diego

Heidi E. Wang

Associate, San Diego

Alexis Guillermo Buz

Associate, San Diego

Joanna Zhang

Associate, San Diego

Jessica Wade

Paralegal Specialist, San Diego

Natasha Leskovsek

Of Counsel, Washington, DC

Phil Mitchell

Partner, New York

Elizabeth Caruso

Associate, New York

Sarah Miller

Associate, New York

Jessica Koffel

Special Counsel, Brussels

Thomas Welk

Senior Counsel, San Diego

Dani Nazemian

Special Counsel, San Diego

Dionne A. Thomas

Associate, San Diego

Ross Eberly

Partner, Santa Monica

Joanna Liebes Hubberts

Partner, San Diego

Chen Chen

Associate, Palo Alto

Alexandra Paterson

Associate, London

Mark Windfeld-Hansen

Senior Counsel, Palo Alto

Stephanie Gentile

Partner, New York

Calvin Lee

Associate, New York

Michael Egan

Partner, Washington, DC

Tania Soris

Associate, New York

Rebecca Ross

Special Counsel, Washington, DC

Francis Wheeler

Senior Counsel, Colorado

Related Practices & Industries

Capital Markets

Life Sciences

Healthcare

Life Sciences and Healthcare Regulatory

Life Sciences Corporate Partnering and Licensing

Compensation and Benefits

Cyber/Data/Privacy

Emerging Companies

Tax

Patent Counseling and Prosecution

Labor and Employment

CFIUS

Enavate Sciences Co-Leads Normunity’s $75 Million Series B

January 13, 2025

Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $75 million Series B financing round of Normunity, a biotechnology company creating novel anticancer therapies. Lawyers Marc Recht, Brandon Fenn and Barry Kuang led the Cooley team advising Enavate Sciences.